IL74383A - S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxy-propoxy)-phenyl)-1,1-diethylurea and salts thereof,their production and pharmaceutical compositions containing them - Google Patents

S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxy-propoxy)-phenyl)-1,1-diethylurea and salts thereof,their production and pharmaceutical compositions containing them

Info

Publication number
IL74383A
IL74383A IL74383A IL7438385A IL74383A IL 74383 A IL74383 A IL 74383A IL 74383 A IL74383 A IL 74383A IL 7438385 A IL7438385 A IL 7438385A IL 74383 A IL74383 A IL 74383A
Authority
IL
Israel
Prior art keywords
diethylurea
acetyl
phenyl
butylamino
tert
Prior art date
Application number
IL74383A
Other versions
IL74383A0 (en
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of IL74383A0 publication Critical patent/IL74383A0/en
Publication of IL74383A publication Critical patent/IL74383A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)

Abstract

1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) S(-)-3-[3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy) phenyl]-1,1-diethylurea (S(-)-celiprolol) and its pharmaceutically acceptable acid addition salts. 1. Claims (for the Contracting State AT) Process for the preparation of S(-)-3-[3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy) phenyl]-1,1-diethylurea (S(-)-celiprolol) and its pharmaceutically acceptable acid addition salts, characterised in that a) the racemate of the formula see diagramm : EP0155518,P10,F1 in the form of the base is reacted with an enantiomer of a chiral resolving acid in a suitable organic solvent, the mixture of the two diastereomeric salts formed in this manner is separated by fractional crystallisation, and, after separating each diastereomeric salt which contains the laevorotatory enantiomer of the compound of the formula I in the S configuration, is reconverted into the free base or a pharmaceutically acceptable addition salt and the resolving acid is recovered, or b) S(+)-3-[3-acetyl-4-(2,3-epoxypropoxy)-phenyl]- 1,1-diethylurea of the formula see diagramm : EP0155518,P10,F2 is reacted with tertiary butylamine in the presence of water at room temperature or with gentle heating to a maximum of 40 degrees C, and then the laevorotatory enantiomer of the compound of the formula I thus obtained is converted as required into a pharmaceutically acceptable addition salt.
IL74383A 1984-03-21 1985-02-19 S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxy-propoxy)-phenyl)-1,1-diethylurea and salts thereof,their production and pharmaceutical compositions containing them IL74383A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410380 DE3410380A1 (en) 1984-03-21 1984-03-21 S (-) - CELIPROLOL, THEIR PHARMACEUTICALLY COMPATIBLE SALT, METHOD FOR THE PRODUCTION THEREOF, USE IN THERAPY AND PHARMACEUTICAL PREPARATIONS

Publications (2)

Publication Number Publication Date
IL74383A0 IL74383A0 (en) 1985-05-31
IL74383A true IL74383A (en) 1988-09-30

Family

ID=6231193

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74383A IL74383A (en) 1984-03-21 1985-02-19 S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxy-propoxy)-phenyl)-1,1-diethylurea and salts thereof,their production and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0155518B1 (en)
JP (1) JPS60209557A (en)
AT (1) ATE45945T1 (en)
AU (1) AU567797B2 (en)
CA (1) CA1236116A (en)
CS (2) CS250682B2 (en)
DD (2) DD232489A1 (en)
DE (2) DE3410380A1 (en)
DK (1) DK124585A (en)
ES (1) ES541424A0 (en)
FI (1) FI83636C (en)
GR (1) GR850496B (en)
HU (1) HU193596B (en)
IL (1) IL74383A (en)
NO (1) NO161254C (en)
PL (2) PL143883B1 (en)
PT (1) PT80135B (en)
RO (2) RO91353B (en)
SU (2) SU1333235A3 (en)
YU (2) YU45707B (en)
ZA (1) ZA852086B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636209A1 (en) * 1986-10-24 1988-04-28 Lentia Gmbh METHOD FOR PRODUCING A BINDER-FREE TABLET-TABLE CELIPROLOL HYDROCHLORIDE GRANULATE
AT388099B (en) * 1986-11-26 1989-04-25 Chemie Holding Ag Process for the production of solid pharmaceutical forms of 3-(3-acetyl-4-(3-tert-butylamino-2- hydroxypropoxy)phenyl)-1,1-diethylurea hydrochloride
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
DE59003337D1 (en) * 1989-10-16 1993-12-09 Danubia Petrochem Polymere Pressling with delayed release of active ingredient.
DE3935736A1 (en) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressed article for sustained pharmaceutical release - contg. poly-lactic acid and polymer of D-3-hydroxybutyric acid, providing good flow properties and easy compression
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN101239937B (en) * 2007-02-07 2010-05-19 上海雅本化学有限公司 Method for preparing optical activity R-(-)-1-benzylcarbonyl-3-aminopyrrolidine and hydrochloride thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT334385B (en) * 1973-12-20 1976-01-10 Chemie Linz Ag PROCESS FOR THE PREPARATION OF NEW PHENOXYPROPYLAMINE DERIVATIVES AND THEIR SALTS
HU170678B (en) * 1973-12-20 1977-08-28
HU170677B (en) * 1973-12-21 1977-08-28
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma

Also Published As

Publication number Publication date
DE3410380A1 (en) 1985-10-10
GR850496B (en) 1985-03-15
NO161254C (en) 1989-07-26
EP0155518B1 (en) 1989-08-30
SU1309908A3 (en) 1987-05-07
JPS60209557A (en) 1985-10-22
EP0155518A2 (en) 1985-09-25
ES8603390A1 (en) 1985-12-16
HU193596B (en) 1987-11-30
YU45707B (en) 1992-07-20
FI850860A0 (en) 1985-03-04
ATE45945T1 (en) 1989-09-15
PT80135B (en) 1987-10-20
YU45246B (en) 1992-05-28
FI83636C (en) 1991-08-12
RO91352A (en) 1987-04-30
NO850834L (en) 1985-09-23
FI850860L (en) 1985-09-22
FI83636B (en) 1991-04-30
PL252462A1 (en) 1985-11-19
SU1333235A3 (en) 1987-08-23
PL252463A1 (en) 1985-11-19
AU567797B2 (en) 1987-12-03
DD232489A1 (en) 1986-01-29
RO91353B (en) 1987-05-01
ZA852086B (en) 1985-11-27
RO91353A (en) 1987-04-30
IL74383A0 (en) 1985-05-31
DE3572656D1 (en) 1989-10-05
AU3972285A (en) 1985-09-26
CS250683B2 (en) 1987-05-14
PT80135A (en) 1985-04-01
HUT37392A (en) 1985-12-28
YU44385A (en) 1987-06-30
ES541424A0 (en) 1985-12-16
DD234860A1 (en) 1986-04-16
RO91352B (en) 1987-05-02
EP0155518A3 (en) 1986-06-25
CS250682B2 (en) 1987-05-14
CA1236116A (en) 1988-05-03
PL143883B1 (en) 1988-03-31
DK124585A (en) 1985-09-22
DK124585D0 (en) 1985-03-20
NO161254B (en) 1989-04-17
YU44485A (en) 1987-06-30

Similar Documents

Publication Publication Date Title
KR860004918A (en) Method for preparing tricyclo compound
IL74383A0 (en) S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea and salts thereof,their production and pharmaceutical compositions containing them
ATE60060T1 (en) SIALOSYLCERAMIDES AND PROCESSES FOR THEIR PRODUCTION.
DE3862901D1 (en) THIOPHENE DERIVATIVE AND PRODUCTION METHOD.
FR2381777A1 (en) PROCESS FOR PREPARING OXAZOLINOAZETIDINONES FROM 6-AMINOPENICILLANIC ACID AND NEW PRODUCTS THUS OBTAINED
DE3272824D1 (en) Novel substituted imidazoles and triazoles, fungicidal compositions containing them, the use thereof for combating fungi and processes for the preparation of intermediates for making the imidazoles and triazoles
JPS5724382A (en) Trithiane derivative and its preparation
PL244610A1 (en) Process for preparing novel derivatives of benzazepine
BR8707026A (en) FUNGICIDE COMPOSITION, COMPOUND, ENANTIOMER, RACEMATE, MIXTURE, PROCESS FOR THE PREPARATION OF PAIR OF ENANTIOMERS AND PROCESS TO COMBAT HARMFUL MICROORGANISMS TO PLANTS
FR2370052A1 (en) LACTAMES USEFUL IN PARTICULAR AS MEDICINES AND THEIR PREPARATION PROCESS
DE3169365D1 (en) Indolo-naphthyridines and their use as medicaments
DE3071497D1 (en) 2-penem compounds; a method for their preparation and pharmaceutical compositions comprising them
FR2432505A1 (en) NOVEL 5-IODO-3-NITRO-4-HYDROXYBENZONITRILE SALTS, THEIR PREPARATION AND COMPOSITIONS CONTAINING THE SAME
JPS5663979A (en) Novel vinyl ether derivative and its preparation
JPH03178970A (en) 2-aromatic-3-halobenzothiazepines